Casopis lekaru ceskych最新文献

筛选
英文 中文
The last ten years with inosine pranobex - from an "old" therapeutic agent to vaccine research, including anti-cancer vaccines. 近十年来,肌苷pranobex从一种“老”的治疗剂发展到包括抗癌疫苗在内的疫苗研究。
Casopis lekaru ceskych Pub Date : 2025-01-01
Jiří Beran, Jiří Slíva
{"title":"The last ten years with inosine pranobex - from an \"old\" therapeutic agent to vaccine research, including anti-cancer vaccines.","authors":"Jiří Beran, Jiří Slíva","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Inosine pranobex (IP), also known as inosine pranobex dimepranol, is an immunomodulatory drug with a history spanning more than fifty years. It was first introduced in the 1970s and has since been licensed in more than 50 countries around the world. It was originally considered a potential drug for AIDS, which raised high hopes at the time of the discovery of the HIV virus. However, after initial interest, its use in this area declined, and for a long time, IP was no longer discussed significantly in professional literature or clinical practice. Renewed interest came only in the last decade, when IP began to reappear in connection with the treatment of acute respiratory infections, diseases caused by human papillomavirus (HPV), and other viral diseases, including COVID-19. It also began to be used as an adjuvant in the foot-and-mouth disease vaccine, and research began on an IP-based anti-tumor vaccine.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"321-323"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol and the cardiovascular system. 酒精和心血管系统
Casopis lekaru ceskych Pub Date : 2025-01-01
Jitka Mlíková Seidlerová
{"title":"Alcohol and the cardiovascular system.","authors":"Jitka Mlíková Seidlerová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mlíková Seidlerová J. Alcohol and the cardiovascular system The consumption of alcohol leads to a variety of direct and indirect effects on the cardiovascular system, as evidenced by numerous epidemiological studies on this topic. The effect of alcohol on the development of cardiovascular complications is influenced not only by the amount of alcohol consumed but also by the drinking pattern (binge drinking vs. regular consumption of moderate amounts of alcohol). This applies to the relationship between alcohol consumption and the rise in blood pressure or the development of arterial hypertension as well.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"294-298"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Surgery Clinic in Hradec Králové. 赫拉德克心脏外科诊所Králové。
Casopis lekaru ceskych Pub Date : 2025-01-01
Jan Harrer, Pavel Žáček
{"title":"Cardiac Surgery Clinic in Hradec Králové.","authors":"Jan Harrer, Pavel Žáček","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"233-235"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stomatology Clinic in Hradec Králové: 80 years of tradition, innovation, and education. hradac口腔诊所Králové: 80年的传统,创新和教育。
Casopis lekaru ceskych Pub Date : 2025-01-01
Jakub Suchánek
{"title":"Stomatology Clinic in Hradec Králové: 80 years of tradition, innovation, and education.","authors":"Jakub Suchánek","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"241-244"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotics in antibiotic treatment - an overview of effectiveness, risks, and recommended practices. 抗生素治疗中的益生菌——有效性、风险和推荐做法概述。
Casopis lekaru ceskych Pub Date : 2025-01-01
Kristýna Fenclová, Irena Murínová
{"title":"Probiotics in antibiotic treatment - an overview of effectiveness, risks, and recommended practices.","authors":"Kristýna Fenclová, Irena Murínová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The administration of antibiotics is associated with the risk of diarrhea due to disruption of the natural gut microbiome, a condition that may persist for several months after the completion of treatment. Probiotics are often used to prevent antibiotic-associated diarrhea; however, their effectiveness in this indication remains a subject of discussion. Meta-analyses confirming the benefits of probiotics are critically assessed by the professional community, and for a long time, their administration was not included in the recommended practices of professional societies. The situation changed in 2023 when probiotics were included in the recommended practices of the World Gastroenterology Organization. This article focuses on the possibilities of administering probiotics in the Czech context, emphasizing currently available medicinal products, their composition, benefits, and potential risks.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 6","pages":"259-261"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opinion of an international panel of experts on the clinical use of microbiome testing. 国际专家小组对微生物组检测临床应用的意见。
Casopis lekaru ceskych Pub Date : 2025-01-01
Monika Cahová, Lucie Najmanová
{"title":"Opinion of an international panel of experts on the clinical use of microbiome testing.","authors":"Monika Cahová, Lucie Najmanová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The international panel of experts has issued a joint consensus opinion on the possibilities of clinical use of gut microbiome analysis with an unequivocal conclusion: The microbiome is an important component of the human body, and its condition is indisputably related to human health. However, the methodology of microbiome composition analysis has not yet been standardized and the interpretation of the results regarding the health of the individual is not yet sufficiently conclusive. Therapeutic counseling based on the results of microbiome testing is strongly discouraged. Further research is required for widespread use in clinical practice.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 2","pages":"68-72"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of haemostatic genes' polymorphisms in men and women with venous thromboembolism in the Czech Republic - a population-based study of cases and controls. 捷克共和国男性和女性静脉血栓栓塞患者中止血基因多态性的患病率-一项基于人群的病例和对照研究。
Casopis lekaru ceskych Pub Date : 2025-01-01
Jan Kvasnička, Zuzana Zenáhlíková, Renata Cífková, Sylvie Šťastná, Zuzana Kovářová Kudrnová, Radka Brzežková, Jaroslava Hájková, Petra Bobčíková, Alena Syrůčková, Petra Linhartová, Martin Ševčík, Daniela Dušková, Tomáš Kvasnička
{"title":"Prevalence of haemostatic genes' polymorphisms in men and women with venous thromboembolism in the Czech Republic - a population-based study of cases and controls.","authors":"Jan Kvasnička, Zuzana Zenáhlíková, Renata Cífková, Sylvie Šťastná, Zuzana Kovářová Kudrnová, Radka Brzežková, Jaroslava Hájková, Petra Bobčíková, Alena Syrůčková, Petra Linhartová, Martin Ševčík, Daniela Dušková, Tomáš Kvasnička","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Our study aimed to determine the prevalence of five polymorphisms of haemostatic genes rs6025 (F5, Leiden), rs1799963 (F2, prothrombin), rs2066865 (FGG), rs2289252 (F11), and rs8176719 (ABO), in 2 cohorts of 924 men and 1,706 women who had venous thromboembolism (VTE), and to compare their occurrence with that in two control groups of healthy individuals (1,516 men and 1,121 women) with no history of VTE in the Czech Republic. Statistically significant increases in the prevalence of rs6025 (F5), rs1799963 (F2), rs2066865 (FGG), rs2289252 (F11) and rs8176719 (ABO) were found in both groups of men and women compared to controls (all p ˂ 0.0001). Both F5 Leiden variants increase the risk of VTE. In male homozygotes 70.56-fold, in male heterozygotes 5.45-fold; in female homozygotes 18.8-fold and in female heterozygotes 5.58-fold. For rs1799963 (F2), the risk of VTE was statistically significantly increased only in the heterozygous variant (3.86-fold in males and 3.95-fold in females). Mutated homozygotes could not be evaluated due to their rare occurrence in the sample. An increase in the risk of VTE of the rs2066865 (FGG) variants was again observed in males (1.8-fold in homozygotes, 1.17-fold in heterozygotes) and females (1.88-fold in homozygotes, 1.32-fold in heterozygotes). Derived variants of rs2289252 (F11) also increased the risk of VTE (1.8-fold in male homozygotes and 1.5-fold in male heterozygotes;1.73-fold in female homozygotes and 1.35-fold in female heterozygotes). Again, we found a higher risk of VTE in individuals with VTE when mutant variants of rs8176719 (ABO) were present. In male homozygotes, it was 4.03-fold and in heterozygotes 2.38-fold. In homozygous women, it was 3.16-fold and in heterozygotes 2.11-fold. Conclusions: Our study confirms that in the Czech Republic, in addition to the known thrombophilic mutations rs6025 (F5) and rs1799963 (F2), there is also a higher prevalence of polymorphisms of the haemostatic gene rs2066865 (FGG), rs2289252 (F11) and rs8176719 (ABO) in both sexes, which can therefore be identified as additional independent heritable risk factors for the VTE.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 4","pages":"143-149"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyslipidemias as rare diseases. 血脂异常是罕见病。
Casopis lekaru ceskych Pub Date : 2025-01-01
Šárka Tesařová, Richard Češka
{"title":"Dyslipidemias as rare diseases.","authors":"Šárka Tesařová, Richard Češka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Dyslipidemias are mostly considered to be diseases with mass incidence. However, there are also several dyslipidemias that occur within the framework of rare diseases. Most of them are genetically determined. In this review, we have focused on three selected diseases for which new therapy is available and significantly change prognosis of the patients. Homozygous familial hypercholesterolaemia is associated with extreme elevation of LDL cholesterol, leading to premature manifestation of atherosclerotic cardiovascular disease in the first decade of life. Thanks to new hypolipidemic drugs such as evinacumab and lomitapide, patients today have a much better prognosis than in the past. Lipodystrophies are a heterogeneous group of diseases characterized by progressive loss of adipose tissue leading to metabolic abnormalities. Due to new causal metreleptine therapy, we can help patients with managing these metabolic complications significantly. Familial chylomicronemia is not associated with an increased risk of atherosclerotic cardiovascular disease, but it is accompanied by extremely high levels of triglycerides, leading to frequent attacks of acute pancreatitis, which can be potentially fatal. Therapy with volanesorsen leads to a reduction of hypertriglyceridemia, thereby reducing the risk of developing acute pancreatitis. Although these diseases are rare, it is necessary to think about them and diagnose them early. Interdisciplinary cooperation is essential during search and treatment of these patients.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"100-104"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathology in Hradec Králové through the ages. hradac的病理学Králové。
Casopis lekaru ceskych Pub Date : 2025-01-01
Petra Kašparová, Aleš Ryška, Ivo Šteiner
{"title":"Pathology in Hradec Králové through the ages.","authors":"Petra Kašparová, Aleš Ryška, Ivo Šteiner","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"197-201"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nephrology and kidney transplantation in Hradec Králové - memories, visions, and achievements. 赫拉代克的肾脏病学和肾移植Králové -记忆、愿景和成就。
Casopis lekaru ceskych Pub Date : 2025-01-01
Sylvie Dusilová Sulková, Petr Moučka, Malgorzata Grofová, Pavel Navrátil, Pavel Navrátil, Igor Guňka, Roman Šafránek, Michaela Matysková, Jaroslav Pacovský, Ivo Novák, Vladimír Palička
{"title":"Nephrology and kidney transplantation in Hradec Králové - memories, visions, and achievements.","authors":"Sylvie Dusilová Sulková, Petr Moučka, Malgorzata Grofová, Pavel Navrátil, Pavel Navrátil, Igor Guňka, Roman Šafránek, Michaela Matysková, Jaroslav Pacovský, Ivo Novák, Vladimír Palička","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"213-217"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书